08:00 , Dec 9, 2013 |  BC Week In Review  |  Company News

Apollo Endosurgery, Allergan deal

Allergan completed the sale of its obesity intervention business to medical device and surgery company Apollo Endosurgery for $75 million in cash up front, a $15 million minority equity interest in Apollo and up to...
08:00 , Nov 4, 2013 |  BC Week In Review  |  Company News

Apollo Endosurgery, Allergan deal

Allergan sold its obesity intervention business, including its Lap-Band adjustable gastric banding system, to medical device and surgery company Apollo Endosurgery for $75 million in cash up front, a $15 million minority equity interest in...
07:00 , Nov 1, 2012 |  BC Innovations  |  Strategy

Mess with Texas

The public spat between the scientific board and management of the Cancer Prevention & Research Institute of Texas is a case study in how commercial and scientific interests can clash when the two sides are...